Novel insights into mycobacterium antigen AG85 biology and implications in countermeasures for M. tuberculosis

Critical Reviews in Eukaryotic Gene Expression

Volumn 22, Issue 3, 2012, Pages 179-187

  Tang, XieMei ^a   Deng, Wanyan ^a   Xie, Jianping ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

Ag85 complex; Mycobacterium tuberculosis; New drug targets; Regulation; Vaccination

Indexed keywords

BCG VACCINE; DNA VACCINE; MYCOBACTERIUM ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; BIOSYNTHESIS; CATALYSIS; CELL WALL; IMMUNE RESPONSE; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPERON; PRIORITY JOURNAL;

ACYLTRANSFERASES; AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CARBOXYLESTERASE; CELL WALL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; RNA, MESSENGER; TUBERCULOSIS;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 84868549274     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v22.i3.10     Document Type: Article

References (53)

1. Bloom BR. Tuberculosis-the global view. N Engl J Med. 2002;346:1434-5.
2. Luthi B, Diacon AH. [Tuberculosis and HIV-features of the co-infection]. Ther Umsch. 2011;68:389-94.
3. Venkatesh KK, Swaminathan S, Andrews JR, Mayer KH. Tuberculosis and HIV co-infection: screening and treatment strategies. Drugs. 2011;71:1133-52.
4. Ohara N, Nishiyama T, Ohara-Wada N, Matsumoto S, Matsuo T, Yamada T. Characterization of the transcriptional initiation regions of genes for the major secreted protein antigens 85C and MPB51 of Mycobacterium bovis BCG. Microb Pathog. 1997;23:303-10.
5. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science. 1997;276:1420-2.
6. Jackson M, Raynaud C, Laneelle MA, Guilhot C, Laurent-Winter C, Ensergueix D, Gicquel B, Daffé M. Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol Microbiol. 1999;31:1573-87.
7. Cole ST, Brosch R, Parkhill J, Gamier T, Churcher C, Harris D, Gordon S. V, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby D, Jagels K, Krogh A, Mclean J, Quail MA, Rajandream MA, Roger J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537-44.
8. Kremer L, Maughan WN, Wilson RA, Dover LG, Besra GS. The M. tuberculosis antigen 85 complex and mycolyltransferase activity. Lett Appl Microbiol. 2002;34: 233-7.
9. Ronning DR, Klabunde T, Besra GS, Vissa VD, Belisle JT, Sacchettini JC. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines. Nat Struct Biol. 2000;7:141-6.
10. Harth G, Lee BY, Wang J, Clemens DL, Horwitz MA. Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect Immun. 1996;64:3038-47.
11. Daffe M. The mycobacterial antigens 85 complex-from structure to function and beyond. Trends Microbiol. 2000;8:438-40.
12. Daffe M, Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol. 1998;39:131-203.
13. Garbe TR, Hibler NS, Deretic V. Isoniazid induces expression of the antigen 85 complex in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1996;40:1754-6.
14. Wilkinson RJ, DesJardin LE, Islam N, Gibson BM, Kanost RA, Wilkinson KA, Poelman D, Eisenach KD, Toossi T. An increase in expression of a Mycobacterium tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes. Mol Microbiol. 2001;39:813-21.
15. Content J, de la Cuvellerie A, De Wit L, Vincent-Levy-Frebault V, Ooms J, De Bruyn J. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect Immun. 1991;59:3205-12.
16. Ohara N, Ohara-Wada N, Kitaura H, Nishiyama T, Mat-sumoto S, Yamada T. Analysis of the genes encoding the antigen 85 complex and MPT51 from Mycobacterium avium. Infect Immun. 1997;65:3680-5.
17. Wilson M, DeRisi J, Kristensen HH, Imboden P, Rane S, Brown PO, Schoolnik GK. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci USA. 1999;96:12833-8.
18. Kazlauskas RJ. Elucidating structure-mechanism relationships in lipases: prospects for predicting and engineering catalytic properties. Trends Biotechnol. 1994;12:464-72.
19. Wilson RA, Maughan WN, Kremer L, Besra GS, Futterer K. The structure of Mycobacterium tuberculosis MPT51 (FbpC 1) defines a new family of non-catalytic alpha/beta hydrolases. J Mol Biol. 2004;335:519-30.
20. Naito M, Ohara N, Matsumoto S, Yamada T. The novel fibronectin-binding motif and key residues of mycobacteria. J Biol Chem. 1998;273:2905-9.
21. Katsube T, Matsumoto S, Takatsuka M, Okuyama M, Ozeki Y, Naito M,Nishiuchi Y, Fujiware N, Yoshimura M, Tsuboi T, Torii M, Oshitani N, Arakawa T, Kobayashi K. Control of cell wall assembly by a histone-like protein in Mycobacteria. J Bacteriol. 2007;189:8241-9.
22. Matsumoto S, Yukitake H, Furugen M, Matsuo T, Mineta T, Yamada T. Identification of a novel DNA-binding protein from Mycobacterium bovis bacillus Calmette-Guerin. Microbiol Immunol. 1999;43:1027-36.
23. Shimoji Y, Ng V, Matsumura K, Fischetti VA, Rambukkana A. A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion. Proc Natl Acad Sci U S A. 1999;96:9857-62.
24. Soares de Lima C, Zulianello L, Marques MA, Kim H, Portugal MI, Antunes SL, Menozzi FD, Ottenhoff TH, Brennan PJ, Pessolani MC. Mapping the laminin-binding and adhesive domain of the cell surface-associated Hlp/ LBP protein from Mycobacterium leprae. Microbes Infect 2005.7.1097-109
25. Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, Deboy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, SalZberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Bishai W, Jacobs WR, Venter JC, Fraser CM. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002;184:5479-90.
26. Romero IC, Mehaffy C, Burchmore RJ, Dobos-Elder K, Brennan P, Walker J. Identification of promoter-binding proteins of the fbp A and C genes in Mycobacterium tuberculosis. Tuberculosis (Edinb). 2010;90:25-30.
27. Alekshun MN, Levy SB. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol. 1999;7:410-3.
28. Via LE, Curcic R, Mudd MH, Dhandayuthapani S, Ul-mer RJ, Deretic V. Elements of signal transduction in Mycobacterium tuberculosis: in vitro phosphorylation and in vivo expression of the response regulator MtrA. J Bacteriol. 1996;178:3314-21.
29. Zahrt TC, Deretic V. An essential two-component signal transduction system in Mycobacterium tuberculosis. J Bacteriol. 2000;182:3832-8.
30. Rajagopalan M, Dziedzic R, Al Zayer M, Stankowska D, Ouimet MC, Bastedo DP, Marczynski GT, Madiraju MV. Mycobacterium tuberculosis origin of replication and the promoter for immunodominant secreted antigen 85B are the targets of MtrA, the essential response regulator. J Biol Chem. 2010;285:15816-27.
31. Nagai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun. 1991;59:372-82.
32. Roberts AD, Sonnenberg MG, Ordway DJ, Furney SK, Brennan PJ, Belisle JT, et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology. 1995;85:502-8.
33. Kashyap RS, Rajan AN, Ramteke SS, Agrawal VS, Kelkar SS, Purohit HJ, Tairi GM, Daginawala HF. Diagnosis of tuberculosis in an Indian population by an indirect ELISA protocol based on detection of Antigen 85 complex: a prospective cohort study. BMC Infect Dis. 2007;7:74.
34. Jarlier V, Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett. 1994;123:11-8.
35. Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, Collons D, Lisle G, Willison RD, Jacobs JR. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 1994;263:227-30.
36. Belanger AE, Besra GS, Ford ME, Mikusova K, Belisle JT, Brennan PJ, Inamine JM. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci U S A. 1996;93:11919-24.
37. Elamin AA, Stehr M, Oehlmann W, Singh M. The my-colyltransferase 85A, a putative drug target of Mycobacterium tuberculosis: development of a novel assay and quantification of glycolipid-status of the mycobacterial cell wall. J Microbiol Methods. 2009;79:358-63.
38. Armitige LY, Jagannath C, Wanger AR, Norris SJ. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infect Immun. 2000;68:767-78.
39. Wiker HG, Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev. 1992;56:648-61.
40. Hetland G, Wiker HG. Antigen 85C on Mycobacterium bovis, BCG and M. tuberculosis promotes monocyte-CR3-mediated uptake of microbeads coated with mycobacterial products. Immunology. 1994;82:445-9.
41. Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, DeWitt CM, Orme IM, Baldwin S, Souza CD, Drowart A, Lozes E, Vandenbussche P, Vooren JP, Margaret AL, Ulmer JB. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med. 1996;2:893-8.
42. Denis O, Tanghe A, Palfliet K, Jurion F, van den Berg TP, Vanonckelen A, Ooms J, Saman E, Ulmer JB, Content J, Huygen K. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun. 1998;66:1527-33.
43. Kamath AT, Rochat AF, Valenti MP, Agger EM, Lingnau K, Andersen P, Lambert P, Siegrist CA. Adult-like antimycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant. PLoS One. 2008;3:e3683.
44. Andersen P, Doherty TM. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005;3:656-62.
45. Doherty TM, Olsen AW, Weischenfeldt J, Huygen K, D'Souza S, Kondratieva TK, Yeremeev VV, Apt A, Raupach B, Grode Leander, Kaufmann S, Andersen P. Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J Infect Dis. 2004;190:2146-53.
46. Weinrich Olsen A, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun. 2001;69:2773-8.
47. Langermans JA, Doherty TM, Vervenne RA, van der Laan T, Lyashchenko K, Greenwald R, Aagaard C, Weiler Horst, Soolingen DV, Dalemans W. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT 6. Vaccine. 2005:23:2740-50.
48. Black GF, Dockrell HM, Crampin AC, Floyd S, Weir RE, Bliss L, Sichali L, Mwaungulu L, kanyongoloka H, Ng-wira B, Warndorff DK, Fine P. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis. 2001;184:322-9.
49. lack GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Black-well JM, Branson K, Chaguluka SD, Donnovan L, Jarman E, King E, Fine PE., Dockrell HM. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002:359:1393-401
50. Floyd S, Ponnighaus JM, Bliss L, Nkhosa P, Sichali L, Msiska G, Fine PE. Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guerin vaccination in northern Malawi. J Infect Dis. 2002;186:807-14.
51. Ponnighaus JM, Fine P., Sterne JA, Wilson RJ, Msosa E, Gruer PJ, Liomba NG, Bliss L, Lucas SB. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet. 1992;339:636-9.
52. Manabe YC, Bishai WR. Latent Mycobacterium tubercu-losis-persistence, patience, and winning by waiting. Nat Med. 2000;6:1327-9.
53. Wayne LG, Sohaskey CD. Nonreplicating persistence of mycobacterium tuberculosis. Annu Rev Microbiol. 2001;55:139-63.